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Abstract
In order to understand the role of brain localized uncoupling proteins, we have examined the UCP2 and BMCP-1 gene
expression in mice brain in two different catabolic states: administration of lipopolysaccharide (LPS) (2.5 mg/kg, i.p.) and
tumour burden. Administration of LPS resulted in an increased UCP2 gene expression both in brain (208%) and cerebellum
(77%). An increase in UCP2 gene expression was also observed after LPS treatment in double knockout mice for tumour
necrosis factor-K (TNF) receptors 1 and 2 (75% in brain and 33% in cerebellum). Tumour growth also resulted in increased
brain UCP2 gene expression (80%) in mice bearing the Lewis lung carcinoma as compared with the non-tumour-bearing
controls. No changes were observed in BMCP-1 mRNA levels of either LPS-injected or tumour-bearing mice. From the
results presented it may be suggested that: (a) the brain may contribute significantly to the increase in energy expenditure
associated with hypermetabolic states such as fever and tumour burden, and (b) the regulation of UCP2 gene expression in
brain does not seem to be influenced by TNF; therefore the action of other cytokines cannot be discarded. ß 2001 Elsevier
Science B.V. All rights reserved.
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1. Introduction
Until very recently, the uncoupling protein-1
(UCP1), present only in brown adipose tissue
(BAT), was considered to be the only mitochondrial
protein carrier that stimulated heat production by
dissipating the proton gradient generated during res-
piration across the inner mitochondrial membrane,
and therefore uncoupling respiration from ATP syn-
thesis. Recently, new uncoupling proteins, UCP2,
UCP3, UCP4 and brain mitochondrial carrier pro-
tein-1 (BMCP-1), have been described in mammal
tissues. While UCP2 is expressed ubiquitously [1,2],
UCP3 is expressed abundantly and speci¢cally in
skeletal muscle in humans [3^6] and also in BAT of
rodents [3,5,7]. BMCP-1 is a recently described mi-
tochondrial carrier with uncoupling activity in yeast
and its mRNA is highly expressed in the central
nervous system of humans and rodents [8]. Finally
UCP4 [9] is another brain speci¢c mitochondrial pro-
tein that has been discovered to have an uncoupling
activity in vitro. Nowadays the possible roles of these
new uncoupling proteins in thermogenesis and en-
ergy balance of intact animals remain to be clearly
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determined. Several factors such as T3 (3,3P,5-triio-
dothyronine), leptin, lipopolysaccharide (LPS), tu-
mour necrosis factor-K (TNF), interleukin-1L (IL-
1L) and other cytokines increase the UCP2 and
UCP3 mRNA levels in animals, suggesting a contri-
bution to thermogenesis (see [10] for review). Di¡er-
ent results suggest that these proteins could have
di¡erent functions depending on the metabolic con-
ditions [11^20]. It is well known that in the course of
di¡erent catabolic states (infection, trauma, tumour
growth) there is an increased energy expenditure (see
[21] for review). It is therefore interesting to relate
this increased energy expenditure with changes in the
level of expression of the di¡erent uncoupling pro-
teins which could have a thermoregulatory role.
Some studies of markers encompassing the human
UCP2/UCP3 locus have revealed a linkage with rest-
ing metabolic rate [22], resting energy expenditure
[23] and anorexia nervosa [24]. Other studies suggest
that UCP2 and UCP3 are determinants of basal en-
ergy expenditure in humans [25,26], whereas no sig-
ni¢cant association between UCP2 and resting en-
ergy expenditure in obese and diabetic humans was
detected [27,28]. On these lines, Faggioni et al. [29]
have reported that UCP2 gene expression in mice is
induced by LPS in several cell types (liver, muscle
and white adipose tissue), and have therefore sug-
gested that it could represent a mechanism for the
increased thermogenesis during infection. In addi-
tion, they also observed that administration of both
interleukin IL-1L and TNF increased UCP2 mRNA
levels in liver, and in muscle and fat tissue, the in-
crease was observed only with the TNF treatment. In
accordance with these results, Masaki et al. [30] also
reported that TNF treatment induced an increase in
UCP2 mRNA expression in rat BAT, white adipose
tissue and skeletal muscle. Our research team has
reported that during tumour growth there is an in-
creased expression of the UCP3 gene in rat skeletal
muscle [31]. This increased expression seems to be
linked to an increased TNF production [32]. These
results are in agreement with the fact that injection
of exogenous TNF is capable of causing fever, leth-
argy, body weight loss and anorexia in healthy ani-
mals [33,34]. Donho¡er et al. [35], monitoring brain
temperatures ^ with copper-constantan thermocou-
ples ^ and the blood £ow to the brain tissue, re-
ported that the brain had thermoregulatory heat pro-
duction in response to cold. It is therefore of major
interest to analyse if the brain might be involved in
the increased energy expenditure observed in other
catabolic states. Bearing all this in mind, the objec-
tives of the present investigation were: (a) to examine
the expression of both UCP2 and BMCP-1 in brain
and cerebellum of mice under di¡erent catabolic con-
ditions, namely LPS-induced fever and tumour bur-
den, and (b) to investigate the role of TNF on the
expression of UCP2 and BMCP-1 in brain in LPS-
induced fever using the TNF double receptor
(TNFR)-knockout model.
2. Materials and methods
2.1. Animals and experimental design
C57BL/6 mice of about 20 weeks of age were used
in the di¡erent experiments. The double TNF recep-
tor-knockout mice were kindly provided by Ho¡-
mann-LaRoche (Switzerland), and they were age-,
weight-, and sex-matched C57BL/6U129J random
hybrids. Knockout mice carrying null mutations in
either p55 (R1) or p75 (R2) TNF receptors were
created by gene targeting in embryonic stem cells.
Mice de¢cient in both receptors were generated by
appropriate crosses between singly de¢cient mice.
The animals were maintained at 22‡C with a regular
light-dark cycle (light on from 08.00 to 20.00 h) and
had free access to food and water. The diet (B.K.
Universal G.J./S.L., Sant Vicenc° del Horts, Barcelo-
na, Spain) consisted of 45.5^48.5% carbohydrate
(3.5% absorbable glucose, 42^45% starch), 18.5%
protein and 3.1% fat (the residue was non-digestible
material). Puri¢ed LPS (Escherichia coli endotoxin
0111:B4) was dissolved in 0.9% pyrogen-free saline
to a concentration of 2 mg/ml and stored at 320‡C.
On the day of injection, the stock solution was
thawed to 37‡C, diluted with sterile saline to the
desired ¢nal concentration and injected intraperito-
neally at a dose of 2.5 mg/kg. Control mice received
an equivalent volume of sterile saline, which did not
exceed 0.15 ml/mouse, intraperitoneally. Colonic
temperatures were constantly monitored during the
course of the experiment and were assessed by
the insertion, 1 cm beyond the rectum, of a plastic
thermocouple connected to a digital thermometer
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(KM330 Kane-May). All the experiment was carried
out at thermoneutral temperature (30‡C); under
these conditions animals respond to LPS with fever
(results not shown), whereas at a subthermoneutral
ambient temperature, the administration of LPS to
mice resulted in hypothermia [36^38]. Our experi-
ment has been performed following the experimental
conditions previously described by Leon et al. [39]
where mice developed fever 23 h after the LPS in-
jection. All injections were performed between 12.00
and 15.00 h. Animals were anaesthetized with a ket-
amine/xylazine (i.p.) mixture 23 h after LPS injec-
tion. Samples of tissues were rapidly excised,
weighed, and frozen in liquid nitrogen. The tu-
mour-bearing animals received an inoculum of
5U105 Lewis lung carcinoma cells obtained from
exponential tumours, given intramuscularly (left
thigh). The development of a nodule at the side of
the injection, growing in size up to 20% of the animal
weight, was considered as an index of e¡ectiveness of
the inoculation. Nearly 100% of the injected animals
developed hind leg tumours, and all of them were
a¡ected by lung metastasis from day 7 onwards.
On day 15 after tumour transplantation, animals
were weighed and anaesthetized with a ketamine/xy-
lazine mixture (i.p.). The tumour was excised from
the hind leg and its mass determined. Samples of
tissues were rapidly excised, weighed, and frozen in
liquid nitrogen.
For LPS injections, mice were placed in one of the
following groups: LPS-injected TNFR wild-type, sa-
line-injected TNFR wild type, LPS-injected TNFR
knockout or saline-injected TNFR knockout.
Tumour-bearing experiments di¡erent experimen-
tal groups were included: control non-tumour-bear-
ing mice and 15 day Lewis lung carcinoma-bearing
mice.
2.2. RNA isolation and Northern blot analysis
Total RNA from brain and cerebellum was ex-
tracted using the acid guanidinium isothiocyanate/
phenol/chloroform method as described by Chomc-
zynski and Sacchi [40]. RNA samples (20 Wg) were
denatured and subjected to 1.2% agarose gel electro-
phoresis containing 6.3% formaldehyde. The RNA in
gels and in ¢lters was visualized with ethidium bro-
mide and photographed by UV transillumination to
ensure the integrity of RNA, to check the loading of
equivalent amounts of RNA and to con¢rm proper
transfer. RNA was transferred to Hybond N mem-
brane (Amersham) in 20Ustandard saline citrate
(SSC; 0.15 M NaCl and 15 mM sodium citrate,
pH 7.0) and ¢xed to the membrane by Gene Linker
(Bio-Rad). Prehybridization was done in a phosphate
bu¡er (250 mM, pH 6.8) containing 7% SDS, 1 mM
EDTA and 1% BSA, for 1 h at 65‡C. Membranes
were hybridized in the same bu¡er with appropriate
probes (approx. 28 Bq/ng) at 65‡C for 18 h. Non-
speci¢cally bound probe was removed by successive
washes in 2USSC+0.1% SDS (10 min at 65‡C) and
1USSC+0.1% SDS (10 min at 65‡C) and
0.1USSC+0.1% SDS (15 min at 65‡C, twice). Specif-
ic hybridization was then detected by autoradiogra-
phy in Hyper¢lm-MP ¢lm (Amersham) using inten-
si¢er screens for 1^4 days at 380‡C. Radiolabelled
probes were prepared by the random priming meth-
od (Boehringer-Mannheim). The probes used were
the entire coding frame for mouse UCP2 [11], a frag-
ment of 979 base pairs of a mouse BMCP-1 cDNA
[8] and a 18S rat ribosomal probe used as hybridiza-
tion/quanti¢cation standard. Blots were quanti¢ed
on a phosphoimager using the Phoretix 1 D gel anal-
ysis (Phoretix, UK). All chemicals were either ob-
tained from Boehringer-Mannheim (Barcelona,
Spain) or from Sigma (St. Louis, MO, USA). Radio-
chemicals were obtained from Amersham (Bucks,
UK). Statistical analysis of the data was performed
by means of Student’s t-test.
3. Results and discussion
The recent discovery of a family of mitochondrial
proteins ^ other than UCP1 [41] ^ with uncoupling
activity (UCP2, UCP3, UCP4 and BMCP-1) has re-
sulted in a considerable amount of information to
elucidate the role of uncoupling of oxidative phos-
phorylation in pathophysiological conditions. It was
reported a long time ago that the brain may have
thermoregulatory heat production in response to
cold [35]. Interestingly UCP2 is expressed abundantly
in the brain, especially in hypothalamus, cerebellum,
ventral septal region, caudal hindbrain and ventricu-
lar region [42]. BMCP-1 is particularly abundant in
cortex, hippocampus, hypothalamus, amygdala and
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thalamus [8]. Bearing this in mind, we investigated
whether the UCP2 and BMCP-1 gene expression in
caudal brain (where structures like the hypothalamus
and thalamus are included) and cerebellum was af-
fected in the course of catabolic conditions where
there is an increased energy expenditure. To accom-
plish this objective we have examined two di¡erent
catabolic conditions: (a) induction of fever by LPS
injection, and (b) tumour growth. In both conditions
increases in energy expenditure have been reported
[43,44].
The results presented in Fig. 1 clearly show that
LPS administration resulted in an increased expres-
sion of UCP2 gene in the brain (208%) in LPS-in-
jected TNFR wild-type mice in comparison with the
saline-injected animals. The same tendency is ob-
served in the cerebellum (77%) (Fig. 2). The role of
cytokines, TNF in particular, in thermoregulation
and in regulating the energy e⁄ciency has been rec-
ognized for a long time. Thus, it was demonstrated
that a single intravenous TNF injection increased
BAT thermogenesis in the young rat, measured as
mitochondrial GDP binding [45] ; a similar e¡ect
was observed when the cytokine was intracerebro-
ventricularly injected [34]. TNF administration to
rats resulted in increases in UCP2 and UCP3 gene
expression in skeletal muscle [31,32], and Faggione et
al. [29] observed an increase in UCP2 mRNA in
liver, skeletal muscle and white adipose tissue follow-
ing cytokine injection in mice. Since LPS administra-
tion is associated with increased cytokine levels
(TNF in particular), we have used gene knockout
mice involving two TNF receptors in order to exam-
ine the role of this cytokine in the expression of
UCP2 and BMCP-1 in brain and cerebellum. In
this model the cytokine cannot bind to its R1 or
R2 receptors due to the lack of the cysteine-rich do-
mains I and II of the receptor, which seem to be
essential for ligand binding. This experimental model
has been successfully used before to report high fe-
brile responses to LPS [39]. LPS injection resulted in
an increased UCP2 gene expression in the double
knockout animals in brain (75%) and cerebellum
Fig. 1. (Upper panel) Northern blots of brain extracts from sa-
line- and LPS-treated mice. Both wild type (WT) and TNF R1
and R2 knockout (KO) animals were used. Expression of both
UCP2 and BMCP-1 mRNA in brain was detected after hybridi-
zation with cDNA probes (see Section 2). Autoradiographs
were subjected to scanning densitometry. The results of two dif-
ferent animals in each group are shown and expressed as arbi-
trary units. (Lower panel) Quanti¢cation of UCP2 (a) and
BMCP-1 (b) mRNA in brain from saline- and LPS-treated
mice. Both wild type and TNF R1 and R2 knockout animals
were used. (a) n = 3 WT, n = 3 WT+LPS, n = 7 KO, n = 4
KO+LPS. Statistical signi¢cance of the di¡erences (LPS versus
saline): **P6 0.01. (b) n = 4 WT, n = 5, WT+LPS, n = 7 KO,
n = 6 KO+LPS.
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(33%) as compared with the saline-injected controls
(Figs. 1 and 2 respectively). These results suggest that
the cytokine alone is not responsible for the in-
creased brain UCP2 gene expression following LPS
injection. These results are in contrast with those
obtained in hepatocytes where TNF seems to be in-
volved in the induction of UCP2 gene expression by
LPS [46]. A possible explanation for this fact is that
other cytokines such as IL-1L, which is also released
following LPS administration, may account for the
observed e¡ect. It is also possible that the induction
of the UCP2 mRNA expression may be a conse-
quence of LPS-related brain injury due to the pro-
duction of reactive oxygen species that follows endo-
toxin exposure [20,47]. Interestingly, no changes were
observed in the levels of expression of the BMCP-1
gene in brain and cerebellum of the LPS-injected
animals (wild type and knockout mice) as compared
with the saline-injected control (Figs. 1 and 2 respec-
tively).
We decided to investigate whether in other catab-
olic states, UCP2 gene expression may be subject to
changes. Taking this into account, Fig. 3 shows that
in tumour-bearing animals the levels of brain UCP2
mRNA were increased (80%) as compared with their
non-tumour-bearing controls. Since increases in en-
ergy expenditure have been reported during tumour
growth [43], the results suggest that the brain UCP2
protein could contribute to the increase in heat pro-
duction. No changes were observed in the levels of
expression of the BMCP-1 gene in brain of the tu-
mour-bearing animals as compared with the control
non-tumour-bearing group (Fig. 3).
In summary, the upregulation of UCP2 gene tran-
scription in brain during catabolic stimulus (LPS in-
jection and cancer), suggests that this organ may
contribute to increased heat production under these
catabolic conditions. The increase in UCP2 mRNA
in brain and cerebellum does not seem to be regu-
lated only by TNF ^ as opposed to what it is found
in peripheral tissues such as skeletal muscle and adi-
pose tissue [29,30]; therefore, other cytokines or me-
Fig. 2. (Upper panel) Northern blots of cerebellum extracts
from saline- and LPS-treated mice. Both wild type (WT) and
TNF R1 and R2 knockout (KO) animals were used. Expression
of both UCP2 and BMCP-1 mRNA in cerebellum was detected
after hybridization with cDNA probes (see Section 2). Autora-
diographs were subjected to scanning densitometry. The results
of two di¡erent animals in each group are shown and expressed
as arbitrary units. (Lower panel) Quanti¢cation of UCP2 (a)
and BMCP-1 (b) mRNA in cerebellum from saline- and LPS-
treated mice. Both wild type and TNF R1 and R2 knockout
animals were used. (a) n = 4 WT, n = 5 WT+LPS, n = 7 KO,
n = 6 KO+LPS. Statistical signi¢cance of the di¡erences (LPS
versus saline): *P6 0.05. (b) n = 4 WT, n = 5, WT+LPS, n = 7
KO, n = 6 KO+LPS.
C
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diators must be involved. In addition, the increase of
the UCP2 mRNA levels could be involved in the
regulation of the activity of certain speci¢c nuclei
in brain [42]. Conversely, BMCP-1 does not change
its expression in these catabolic models, suggesting
that under these conditions it may have a di¡erent
function than that of UCP2. Future work will allow
a better assessment of the importance of an increased
brain energy expenditure in response to di¡erent
pathological conditions.
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